Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2005
03/10/2005WO2005000355A8 Treatment of tumor by cotransferring chemotherapeutic agent with cytokine gene
03/10/2005WO2004090112A3 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
03/10/2005WO2004081040A3 Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications
03/10/2005WO2004075723A3 Methods for the early diagnosis of ovarian cancer
03/10/2005WO2004057017A3 Detection of small nucleic acids
03/10/2005WO2004055161A3 Large scale production of packaged alphavirus replicons
03/10/2005WO2003093409A3 Promoters exhibiting endothelial cell specificity and methods of using same
03/10/2005WO2003087834A3 High throughput analysis of recombinant proteins in multi-well plates
03/10/2005WO2002094989A3 Retroviral vectors and methods of using same
03/10/2005WO2001066772A9 Heparinase iii and uses thereof
03/10/2005US20050055072 Light activated gene transduction for cell targeted gene delivery in the spinal column
03/10/2005US20050054845 Thymosin augmentation of genetic immunization
03/10/2005US20050054836 Chimeric molecules to modulate gene expression
03/10/2005US20050054726 Vaccine
03/10/2005US20050054604 Labile linkage for compound delivery to a cell
03/10/2005US20050054602 Oligonucleotides containing activated lymphocytes; antibody therapy; antiallergens; skin disorders
03/10/2005US20050054601 Modified polynucleotides with phosphorothiolate linkage; animal growth regulators; immunomoderators; immunotherapy ; autoimmune disease
03/10/2005US20050054600 Modified protein kinase a-specific oligonucleotides and methods of their use
03/10/2005US20050054599 using gene expression to target, detection response to stress
03/10/2005US20050054595 Genetic engineering; gene expression of target agent
03/10/2005US20050054594 Methods for particle-assisted polynucleotide immunization using a pulsed electric field
03/10/2005US20050054593 New drug
03/10/2005US20050054592 Alzheimer's disease; Parkinson's disease; isolated nucleic acids
03/10/2005US20050054591 Yin yang-1
03/10/2005US20050054576 Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
03/10/2005US20050054575 Peptide agonists of prostate-specific antigen and uses therefor
03/10/2005US20050054561 Abuse-resistant amphetamine compounds
03/10/2005US20050054105 Expression vector comprising inverted terminal repeats for use as gene transfer tool in genetic engineering; genetic vaccines
03/10/2005US20050054090 MHC class II antigen-presenting systems and methods for activating CD4cells
03/10/2005US20050054036 Growth factor isoform
03/10/2005US20050054018 Using cell cycle checkpoint activation modulators to prevent and treat cell proliferative disorders
03/10/2005US20050053995 Staphylococcus aureus genes and polypeptides
03/10/2005US20050053976 Chimeric oligomeric compounds and their use in gene modulation
03/10/2005US20050053970 Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype
03/10/2005US20050053965 Double stranded RNA compound for use the prevention and treatment of inflammatory and autoimmune disorders
03/10/2005US20050053958 Using allelic variation in breast cancer genes (BRCA) as diagnostic tool in detection of mammary gland cell proliferative disorders
03/10/2005US20050053943 Transmembrane protein for use in the diagnosis, detection, prevention and treatment of cell proliferative disorders; immunotherapy
03/10/2005US20050053935 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
03/10/2005US20050053919 Using negative-sense single stranded RNA viral sequences as diagnostic tool in detection of respiratory syncytial viral infection
03/10/2005US20050053603 Monocyte chemoattractant protein for treatment of liver diseases and antibodies thereof
03/10/2005US20050053590 Endothelium-targeting nanoparticle for reversing endothelial dysfunction
03/10/2005US20050053587 Genetically-engineered bone marrow stromal cells; expression vectors comprise promoter, internal ribosome entry site, marker sequence, and sequence encoding erythropoietin; improved biocompatbility; tissue repair; angiogenesis
03/10/2005US20050053586 Proliferation/differentiation inhibition; storage stability
03/10/2005US20050053583 Method of inhibiting prion protein
03/10/2005US20050053581 Which effect p53 binding/inactivation; enhances efficacy of such viruses for treating cancer; liposomes
03/10/2005US20050053579 Conjugates of cytokines, chemokines, and interferons; genetic vaccines; for reducing tumor growth
03/10/2005US20050051706 Uncaging device
03/10/2005CA2537184A1 Gene therapy for skin disorders using needleless syringes
03/10/2005CA2536911A1 Antibody against nox1 polypeptide, method of diagnosing cancer with the use of nox1 gene and method of screening cancer growth inhibitor
03/10/2005CA2536909A1 Kidney derived stem cells and methods for their isolation, differentiation and use
03/10/2005CA2536471A1 Aav vectors for in vivo gene therapy of rheumatoid arthritis
03/10/2005CA2536333A1 Interfering rna duplex having blunt-ends and 3'-modifications
03/10/2005CA2535816A1 Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders
03/10/2005CA2535522A1 Fsh glycosylation mutant
03/09/2005EP1512749A2 DNA to be introduced into biogenic gene, gene introducing vector, cell, and method for introducing information into biogenic gene
03/09/2005EP1512743A1 Conditional modification of siRNAs expression
03/09/2005EP1512742A1 Conditional modification of sirnas expression
03/09/2005EP1512739A1 Chrondrocyte therapeutic delivery system
03/09/2005EP1512415A1 Decoy composition for treating and preventing inflammatory disease
03/09/2005EP1511857A1 Pthrp-based prediction and diagnosis of bone disease
03/09/2005EP1511853A2 Regulation of novel human asparagine-hydroxylases
03/09/2005EP1511844A2 Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules
03/09/2005EP1511840A1 Process for preparing an adenovirus-containing preparation
03/09/2005EP1511759A1 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof.
03/09/2005EP1511509A1 Compositions and methods for treating diabetes
03/09/2005EP1511506A1 Compositions and methods for preventing, treating and diagnosing diabetes
03/09/2005EP1511505A2 Novel therapies and methods of screening for therapeutic compounds
03/09/2005EP1511393A1 A method of improving the growth performance of an animal
03/09/2005EP1392354B1 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic wounds
03/09/2005EP1237916B1 Ing2, an iaps associated cell cycle protein, compositions and methods of use
03/09/2005EP1159423B1 Uses of transgenic animals containing a type x collagen mutant
03/09/2005EP1108026B1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same
03/09/2005EP0991425B1 Pro
03/09/2005EP0935471B1 Mononuclear phagocytes in therapeutic drug delivery
03/09/2005EP0756005B1 Gene coding for adseverin
03/09/2005CN1592781A Adipose-derived stem cells and lattices
03/09/2005CN1592755A Anti-angiogenic peptides
03/09/2005CN1592638A Promoters exhibiting endothelial cell specificity and methods of using same
03/09/2005CN1592637A Medicinal compositions
03/09/2005CN1590407A Multifunctional blood forming receptor agonist
03/09/2005CN1590404A Antigenic meningococcal peptides
03/09/2005CN1192112C Mutant herpes simplex viruses and uses thereof
03/09/2005CN1192109C Anticoagulant fusion protein anchored to cell membrane
03/09/2005CN1191872C Device for delivery of macromolecules into cells
03/09/2005CN1191865C Stabilization of lipid DNA formulations during nebulization
03/09/2005CN1191862C Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery
03/09/2005CN1191851C Polypeptide comprising amino acid of AN N-terminal choline binding protein truncate, vaccine derived therefrom and uses thereof
03/09/2005CN1191823C Cell for producing alginate capsules
03/08/2005US6864229 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same
03/08/2005US6864085 Evpression vector for use as tool in genetic engineering
03/08/2005US6864082 Modified viral surface proteins for binding to extracellular matrix components
03/08/2005US6864078 14790, novel protein kinase molecule and uses therefor
03/08/2005US6864064 18891, a novel human lipase
03/08/2005US6863894 Mutant Salmonella; anticancer agents
03/08/2005US6863892 Diagnosi and treatment of cancer; obtain tissue sample, monitor gene expression in sample, monitor methylation in sample, compare to control, evaluate for cancer
03/08/2005US6863889 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, immune, autoimmune, bone, nervous system, inflammatory and skin disorders
03/08/2005CA2480712A1 Chondrocyte therapeutic delivery system
03/03/2005WO2005019478A1 Methods and compositions for modulating herpesviral replication and transcription activator
03/03/2005WO2005019453A2 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
03/03/2005WO2005019433A2 VIRALLY-ENCODED RNAs AS SUBSTRATES, INHIBITORS AND DELIVERY VEHICLES FOR RNAi
1 ... 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 ... 870